A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
OTC muscle and joint pain relievers may cause chemical burns in rare cases, U.S. health regulators warned on Thursday. Products that contain menthol, methyl salicylate, or capsaicin - including major brands such as Johnson & Johnson’s Bengay, Sanofi’s Icy Hot, Capzasin and Flexall, and Rohto Pharmaceutical’s Mentholatum — were found to cause first- to third-degree burns. Reuters